Lyme Disease Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems, Oxford Immunotec

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lyme Disease pipeline constitutes 7+ key companies continuously working towards developing 7+ Lyme Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Lyme Disease Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Lyme Disease Market.

The Lyme Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Lyme Disease Pipeline Report: https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Lyme Disease treatment therapies with a considerable amount of success over the years.
• Lyme Disease companies working in the treatment market are CyanVac, Flightpath Biosciences, Inc, Cortene Inc., Tarsus Pharmaceuticals, Inc, Valneva SE, and others, are developing therapies for the Lyme Disease treatment
• Emerging Lyme Disease therapies in the different phases of clinical trials are- BLB 400, FP-100, CT38, TP-05, VLA15, and others are expected to have a significant impact on the Lyme Disease market in the coming years.
• In September 2024, Valneva and Pfizer announced positive results from the Phase II VLA15-221 clinical trial, evaluating a second booster dose of their Lyme disease vaccine candidate, VLA15, given one year after the initial booster. VLA15 is an investigational multivalent protein subunit vaccine targeting the outer surface protein A (OspA) of Borrelia burgdorferi, the bacteria responsible for Lyme disease.

Lyme Disease Overview
The most prevalent vector-borne illness, Lyme disease (also known as Lyme borreliosis), is brought on by the bacteria Borrelia burgdorferi and, less frequently, Borrelia mayonii. It is a prevalent illness in the United States that is brought on by the bite of an infected blacklegged tick, sometimes referred to as a bear or deer tick. The illness impacts both people and animals.

Get a Free Sample PDF Report to know more about Lyme Disease Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Lyme Disease Drugs Under Different Phases of Clinical Development Include:
• BLB 400: CyanVac
• FP-100: Flightpath Biosciences, Inc
• CT38: Cortene Inc.
• TP-05: Tarsus Pharmaceuticals, Inc
• VLA15: Valneva SE

Lyme Disease Route of Administration
Lyme Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Lyme Disease Molecule Type
Lyme Disease Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Lyme Disease Pipeline Therapeutics Assessment
• Lyme Disease Assessment by Product Type
• Lyme Disease By Stage and Product Type
• Lyme Disease Assessment by Route of Administration
• Lyme Disease By Stage and Route of Administration
• Lyme Disease Assessment by Molecule Type
• Lyme Disease by Stage and Molecule Type

DelveInsight's Lyme Disease Report covers around 7+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Lyme Disease product details are provided in the report. Download the Lyme Disease pipeline report to learn more about the emerging Lyme Disease therapies at:
https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Lyme Disease Therapeutics Market include:
Key companies developing therapies for Lyme Disease are - Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems, Inc, Oxford Immunotec USA, Inc., and others.

Lyme Disease Pipeline Analysis:
The Lyme Disease pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Lyme Disease with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Lyme Disease Treatment.
• Lyme Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Lyme Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Lyme Disease market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Lyme Disease drugs and therapies-
https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Lyme Disease Pipeline Market Drivers
• Increasing Prevalence of Lyme disease, development in studies on the treatment of Lyme disease are some of the important factors that are fueling the Lyme Disease Market.

Lyme Disease Pipeline Market Barriers
• However, lack of pipeline therapies, risk for significant long-term health consequences and other factors are creating obstacles in the Lyme Disease Market growth.

Scope of Lyme Disease Pipeline Drug Insight
• Coverage: Global
• Key Lyme Disease Companies: CyanVac, Flightpath Biosciences, Inc, Cortene Inc., Tarsus Pharmaceuticals, Inc, Valneva SE, and others
• Key Lyme Disease Therapies: BLB 400, FP-100, CT38, TP-05, VLA15, and others
• Lyme Disease Therapeutic Assessment: Lyme Disease current marketed and Lyme Disease emerging therapies
• Lyme Disease Market Dynamics: Lyme Disease market drivers and Lyme Disease market barriers

Request for Sample PDF Report for Lyme Disease Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Lyme Disease Report Introduction
2. Lyme Disease Executive Summary
3. Lyme Disease Overview
4. Lyme Disease- Analytical Perspective In-depth Commercial Assessment
5. Lyme Disease Pipeline Therapeutics
6. Lyme Disease Late Stage Products (Phase II/III)
7. Lyme Disease Mid Stage Products (Phase II)
8. Lyme Disease Early Stage Products (Phase I)
9. Lyme Disease Preclinical Stage Products
10. Lyme Disease Therapeutics Assessment
11. Lyme Disease Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Lyme Disease Key Companies
14. Lyme Disease Key Products
15. Lyme Disease Unmet Needs
16 . Lyme Disease Market Drivers and Barriers
17. Lyme Disease Future Perspectives and Conclusion
18. Lyme Disease Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Lyme Disease Market https://www.delveinsight.com/report-store/lyme-disease-ld-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Lyme Disease Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Lyme Disease Epidemiology https://www.delveinsight.com/report-store/lyme-disease-ld-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Lyme Disease Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports Offered By DelveInsight:
• Parp Poly Adp-ribose Polymerase Inhibitor Market: https://www.delveinsight.com/report-store/poly-adp-ribose-polymerase-1-parp-inhibitor-pipeline-insight
• Erectile Dysfunction Market: https://www.delveinsight.com/report-store/erectile-dysfunction-market
• Necrotizing Enterocolitis Market: https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-market
• Arteriovenous Malformations Market: https://www.delveinsight.com/report-store/vascular-malformations-market
• Mammography Devices Market: https://www.delveinsight.com/report-store/mammography-devices-market
• Global Kinase Inhibitor Market: https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market-insight

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.